Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 691594, 8 pages
http://dx.doi.org/10.1155/2015/691594
Research Article

Ergosterol Alleviates Kidney Injury in Streptozotocin-Induced Diabetic Mice

Changchun University of Traditional Chinese Medicine, Jilin, Changchun 130117, China

Received 1 September 2015; Revised 29 October 2015; Accepted 29 October 2015

Academic Editor: Youn C. Kim

Copyright © 2015 Li Ang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Perkowski, T. Basiński, M. Wiwart, M. Kostecki, M. Buśko, and A. Matysiak, “The effect of environmental conditions on ergosterol and trichothecene content of naturally contaminated oat grain,” Annals of Agricultural and Environmental Medicine, vol. 15, no. 2, pp. 271–276, 2008. View at Google Scholar · View at Scopus
  2. A. Gil-Ramírez, V. Caz, R. Martin-Hernandez et al., “Modulation of cholesterol-related gene expression by ergosterol and ergosterol-enriched extracts obtained from Agaricus bisporus,” European Journal of Nutrition, 2015. View at Publisher · View at Google Scholar
  3. K. Leiva, N. Werner, D. Sepúlveda et al., “Identification and functional characterization of the CYP51 gene from the yeast Xanthophyllomyces dendrorhous that is involved in ergosterol biosynthesis,” BMC Microbiology, vol. 15, article 89, 2015. View at Publisher · View at Google Scholar
  4. P.-L. Cai, X.-P. He, N. Liu, and B.-R. Zhang, “Effect of over-expression of sterol C-22 desaturase on ergosterol production in yeast strains,” Wei Sheng Wu Xue Bao, vol. 47, no. 2, pp. 274–279, 2007. View at Google Scholar · View at Scopus
  5. H. Wiseman, “Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action,” FEBS Letters, vol. 326, no. 1–3, pp. 285–288, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. M. S. Newman, T. R. Brandon, M. N. Groves, W. L. Gregory, S. Kapur, and D. T. Zava, “A liquid chromatography/tandem mass spectrometry method for determination of 25-hydroxy vitamin D2 and 25-hydroxy vitamin D3 in dried blood spots: a potential adjunct to diabetes and cardiometabolic risk screening,” Journal of Diabetes Science and Technology, vol. 3, no. 1, pp. 156–162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Yousefi Rad, M. Djalali, F. Koohdani et al., “The effects of vitamin D supplementation on glucose control and insulin resistance in patients with diabetes type 2: a randomized clinical trial study,” Iranian Journal of Public Health, vol. 43, no. 12, pp. 1651–1656, 2014. View at Google Scholar · View at Scopus
  8. K. A. S. Al-Shoumer and T. M. Al-Essa, “Is there a relationship between vitamin D with insulin resistance and diabetes mellitus?” World Journal of Diabetes, vol. 6, no. 8, pp. 1057–1064, 2015. View at Publisher · View at Google Scholar
  9. C. Qian, C. Zhu, W. Yu, X. Jiang, F. Zhang, and L. Malaval, “High-fat diet/low-dose streptozotocin-induced type 2 diabetes in rats impacts osteogenesis and Wnt signaling in bone marrow stromal cells,” PLoS ONE, vol. 10, no. 8, Article ID e0136390, 2015. View at Publisher · View at Google Scholar
  10. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 33, supplement 1, pp. S62–S69, 2009. View at Publisher · View at Google Scholar
  11. International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 6th edition, 2014.
  12. J. M. Chehade, M. Gladysz, and A. D. Mooradian, “Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management,” Drugs, vol. 73, no. 4, pp. 327–339, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Schmatz, L. B. Perreira, N. Stefanello et al., “Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats,” Biochimie, vol. 94, no. 2, pp. 374–383, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Cordero-Herrera, M. A. Martín, L. Bravo, L. Goya, and S. Ramos, “Cocoa flavonoids improve insulin signalling and modulate glucose production via AKT and AMPK in HepG2 cells,” Molecular Nutrition and Food Research, vol. 57, no. 6, pp. 974–985, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. R. K. Avramoglu, H. Basciano, and K. Adeli, “Lipid and lipoprotein dysregulation in insulin resistant states,” Clinica Chimica Acta, vol. 368, no. 1-2, pp. 1–19, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Z. Mehdi, G. Vardatsikos, S. K. Pandey, and A. K. Srivastava, “Involvement of insulin-like growth factor type 1 receptor and protein kinase Cδ in bis(maltolato)oxovanadium(IV)-induced phosphorylation of protein kinase B in HepG2 cells,” Biochemistry, vol. 45, no. 38, pp. 11605–11615, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Guo, H. Yoshitomi, M. Gao et al., “Guava leaf extracts promote glucose metabolism in SHRSP.Z-Leprfa/Izm rats by improving insulin resistance in skeletal muscle,” BMC Complementary and Alternative Medicine, vol. 13, article 52, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. C. J. Bailey and C. Day, “Traditional plant medicines as treatments for diabetes,” Diabetes Care, vol. 12, no. 8, pp. 553–564, 1989. View at Publisher · View at Google Scholar · View at Scopus
  19. B. de Courten, A. Mousa, N. Naderpoor, H. Teede, M. P. de Courten, and R. Scragg, “Vitamin D supplementation for the prevention of type 2 diabetes in overweight adults: study protocol for a randomized controlled trial,” Trials, vol. 16, article 335, 2015. View at Publisher · View at Google Scholar
  20. N. Tsugawa, T. Okano, A. Takeuchi, M. Kayama, and T. Kobayashi, “Metabolism of orally administered ergosterol and 7-dehydrocholesterol in rats and lack of evidence for their vitamin D biological activity,” Journal of Nutritional Science and Vitaminology, vol. 38, no. 1, pp. 15–25, 1992. View at Publisher · View at Google Scholar · View at Scopus
  21. B.-S. Cha, T. P. Ciaraldi, K.-S. Park, L. Carter, S. R. Mudaliar, and R. R. Henry, “Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARγ agonists,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 289, no. 1, pp. E151–E159, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Saravanan and P. Ponmurugan, “Ameliorative potential of S-allylcysteine: effect on lipid profile and changes in tissue fatty acid composition in experimental diabetes,” Experimental and Toxicologic Pathology, vol. 64, no. 6, pp. 639–644, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Yang, D. M. Zhang, J. H. Liu et al., “Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice,” Journal of Ethnopharmacology, vol. 169, pp. 49–59, 2015. View at Publisher · View at Google Scholar
  24. G. Bayramoglu, H. Senturk, A. Bayramoglu et al., “Carvacrol partially reverses symptoms of diabetes in STZ-induced diabetic rats,” Cytotechnology, vol. 66, no. 2, pp. 251–257, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. S.-W. Hahm, J. Park, and Y.-S. Son, “Opuntia humifusa stems lower blood glucose and cholesterol levels in streptozotocin-induced diabetic rats,” Nutrition Research, vol. 31, no. 6, pp. 479–487, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Deng, Y. Gu, X. Hou et al., “Association between uric acid, cancer incidence and mortality in patients with type 2 diabetes: Shanghai diabetes registry study,” Diabetes/Metabolism Research and Reviews, 2015. View at Publisher · View at Google Scholar
  27. M.-X. Wang, Y.-L. Liu, Y. Yang, D.-M. Zhang, and L.-D. Kong, “Nuciferine restores potassium oxonate-induced hyperuricemia and kidney inflammation in mice,” European Journal of Pharmacology, vol. 747, pp. 59–70, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. W.-D. Li, K.-F. Fu, G.-M. Li et al., “Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus,” World Journal of Gastroenterology, vol. 21, no. 32, pp. 9607–9613, 2015. View at Publisher · View at Google Scholar
  29. S. Jiang, D. Ren, J. Li et al., “Effects of compound K on hyperglycemia and insulin resistance in rats with type 2 diabetes mellitus,” Fitoterapia, vol. 95, pp. 58–64, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. P. M. P. Vareda, L. L. Saldanha, N. A. D. P. Camaforte, N. M. Violato, A. L. Dokkedal, and J. R. Bosqueiro, “Myrcia bella leaf extract presents hypoglycemic activity via PI3k/Akt insulin signaling pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 543606, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. G. D. Holman and M. Kasuga, “From receptor to transporter: insulin signalling to glucose transport,” Diabetologia, vol. 40, no. 9, pp. 991–1003, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. L.-Y. Wang, Y. Wang, D.-S. Xu, K.-F. Ruan, Y. Feng, and S. Wang, “MDG-1, a polysaccharide from Ophiopogon japonicus exerts hypoglycemic effects through the PI3K/Akt pathway in a diabetic KKAy mouse model,” Journal of Ethnopharmacology, vol. 143, no. 1, pp. 347–354, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. H. He, X. Chang, J. Gao, L. Zhu, M. Miao, and T. Yan, “Salidroside mitigates sepsis-induced myocarditis in rats by regulating IGF-1/PI3K/Akt/GSK-3β signaling,” Inflammation, vol. 38, no. 6, pp. 2178–2184, 2015. View at Publisher · View at Google Scholar
  34. M. F. El-Refaei, S. H. Abduljawad, and A. H. Alghamdi, “Alternative medicine in diabetes—role of angiogenesis, oxidative stress, and chronic inflammation,” The Review of Diabetic Studies, vol. 11, no. 3-4, pp. 231–244, 2014. View at Publisher · View at Google Scholar
  35. T. Chen, Y. Mou, J. Tan et al., “The protective effect of CDDO-Me on lipopolysaccharide-induced acute lung injury in mice,” International Immunopharmacology, vol. 25, no. 1, pp. 55–64, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Ma, L. Zhu, J. Wang et al., “Anti-inflammatory effects of water extract of Taraxacum mongolicum hand.-Mazz on lipopolysaccharide-induced inflammation in acute lung injury by suppressing PI3K/Akt/mTOR signaling pathway,” Journal of Ethnopharmacology, vol. 168, pp. 349–355, 2015. View at Publisher · View at Google Scholar